title: Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?
authors.affiliation: Department of Rheumatology, Birmingham City Hospital; amarsrinivasa@nhs.net.
authors.forename: Amar
authors.initials: A
authors.lastname: Srinivasa
authors.affiliation: Birmingham City Hospital.
authors.forename: Sofia
authors.initials: S
authors.lastname: Tosounidou
authors.affiliation: Department of Rheumatology, Birmingham City Hospital, Birmingham, UK.
authors.forename: Caroline
authors.initials: C
authors.lastname: Gordon
mesh_terms: D015746:Abdominal Pain / Q000139:chemically induced / Q000453:epidemiology*; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004408:Dysgeusia / Q000139:chemically induced / Q000453:epidemiology*; D004415:Dyspepsia / Q000139:chemically induced / Q000453:epidemiology*; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects* / Q000627:therapeutic use; D015994:Incidence; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine